Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 4272-4281

  Scotto, Christian ^a   Deloulme, Jean Christophe ^a   Rousseau, Denis ^b   Chambaz, Edmond ^a   Baudier, Jacques ^a,c  

^a CEA GRENOBLE   (France)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; CALCIUM IONOPHORE; PROTEIN P53; PROTEIN S 100;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL DENSITY; CELL GROWTH; CELL TRANSFORMATION; CONTACT INHIBITION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE OVEREXPRESSION; GLIA CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; TEMPERATURE; ULTRAVIOLET IRRADIATION;

ANIMALIA;

EID: 0031834812     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.4272     Document Type: Article

References (50)

1. Allore, R., D. O'Hanlon, R. Price, K. Neilson, H. F. Willard, D. R. Cox, A. Marks, and R. J. Dunn. 1988. Gene encoding the β-subunit of S100 protein is on chromosome 21: implication for Down syndrome. Science 239:1311-1313.
2. Aloni-Grinstein, R., D. Schwartz, and V. Rotter. 1995. Accumulation of wild-type p53 protein upon γ-irradiation induces a G2 arrest-dependent immunoglobulin κ light chain gene expression. EMBO J. 14:1392-1401.
3. Artuso, M., A. Esteve, H. Brésil, M. Vuillaume, and J. Hall. 1995. The role of the Ataxia telangiectasia gene in the p53, WAF1/CIP1 (p21) and GADD45-mediated response to DNA damage produced by ionising radiation. Oncogene 11:1427-1435.
4. Asai, A., Y. Miyagi, A. Sugiyama, M. Gamanuma, S. I. Hong, S. Takamoto, K. Nomura, M. Matsutani, K. Takakura, and Y. Kuchino. 1994. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. J. Neuro-Oncol. 19:259-268.
5. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
6. 2+ binding on S100B protein. J. Biol. Chem. 261:8192-8203.
7. Baudier, J., D. Mochly-Rosen, A. Newton, S. H. Lee, D. E. Koshland, and R. D. Cole. 1987. Comparison of S100b protein with calmodulin: interactions with melitin and microtubule-associated τ proteins and inhibition of phosphorylation of τ proteins by protein kinase C. Biochemistry 26:2886-2893.
8. Baudier, J., E. Bergeret, N. Bertacchi, H. Weintraub, J. Gagnon, and J. Garin. 1995. Interactions of myogenic bHLH transcription factors with calcium-binding calmodulin and S100a (αα) proteins. Biochemistry 34:7834-7846.
9. Baudier, J., C. Delphin, D. Grunwald, S. Khoshbin, and J. J. Lawrence. 1992. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100B-binding protein. Proc. Natl. Acad. Sci. USA 89:11627-11631.
10. Bonfoco, E., D. Krainc, M. Ankarcrona, P. Nicotera, and S. A. Lipton. 1995. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxyde/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92:7162-7166.
11. Caelles, C., A. Heimberg, and M. Karim. 1994. p53 dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-224.
12. Chen, X., L. J. Ko, L. Jayaraman, and C. Prive. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438-2451.
13. Coppolino, M., M. J. Woodside, N. Demaurex, S. Grinstein, R. St-Arnaud, and S. Dedhar. 1997. Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 286:843-847.
14. Delphin, C., and J. Baudier. 1994. The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of ras-transformed embryo fibroblasts growth arrest. J. Biol. Chem. 269:29579-29587.
15. 2* response amplitude and duration. Nature 286:855-858.
16. El-Deiry, W. S., T. Tokino, V. E. Velculenscu, D. B. Levy, R. Parson, J. M. Trent, D. Lin, E. W. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumour suppression. Cell 75:817-825.
17. Fano, G., M. A. Mariggio, P. Angelella, I. Nicoletti, A. Antonica, S. Fulle, and P. Calissano. 1993. The S100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience 53:919-925.
18. Gannon, J. V., and D. P. Lane. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349:802-805.
19. Gottlieb, E., R. Haffner, T. Von Rüde, E. F. Wagner, and M. Oren. 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of Il-3-dependent hematopoietic cells following Il-3 withdrawal. EMBO J. 13:1368-1374.
20. Griffin, W. S. T., L. C. Stanley, C. Ling, L. White, V. MacLeod, L. J. Perrot, C. L. White, and C. Araoz. 1989. Brain interleukin 1 and S100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615.
21. Haglid, K., A. Hamberger, H. Hansson, H. Hyden, L. Persson, and L. Ronnbach. 1976. Cellular and subcellular distribution of the S100 protein in rabbit and rat central nervous system. J. Neurosci. Res. 2:175-192.
22. Haupt, Y., S. Rowan, E. Shaulian, K. H. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9:2170-2183.
23. He, J., C. M. De Castro, G. R. Vandenbark, J. Busciglio, and D. Gabuzda. 1997. Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc. Natl. Acad. Sci. USA 94:3954-3959.
24. 2+ -binding proteins in human neurodegenerative disorders. Trends Neurol. Sci. 15:259-264.
25. Herschman, H. R., L. Levine, and J. De Vellis. 1971. Appearance of a brain-specific antigen (S100-protein) in the developing rat brain. J. Neurochem. 18:629-633.
26. Kitamura, Y., S. Shimohama, W. Kamoshima, Y. Matsuoka, Y. Nomura, and T. Taniguchi. 1997. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232:418-421.
27. Kligman, D., and D. R. Murshak. 1985. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA 82:7136-7139.
28. Knippschild, U., M. Oren, and W. Deppert. 1996. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene 12:1755-1765.
29. Kolber, A. R., A. S. Permual, M. N. Goldstein, and B. W. Moore. 1978. Drug-induced differentiation of a rat glioma in vitro: the expression of S100, a glial specific protein and steroid sulfatase. Brain Res. 143:513-520.
30. Labourdette, G., and A. Marks. 1975. Synthesis of S100 protein in monolayer cultures of rat-glial cells. Eur. J. Biochem. 58:73-79.
31. Lee, S. W., C. Tomasetto, K. Swisshelm, K. Keyomarsi, and R. Sager. 1992. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc. Natl. Acad. Sci. USA 89:2504-2508.
32. Marks, A., D. Petsche, D. O'Hanlon, P. C. Kwong, R. Stead, R. Dunn, R. Baumal, and S. K. Liao. 1990. S100 protein expression in human melanoma cells: comparison of levels of expression among different cell lines and individual cells in different phases of the cell cycle. Exp. Cell Res. 187:59-64.
33. Marshak, D. R., S. A. Pesce, L. C. Stanley, and W. S. T. Griffin. 1991. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging 13:1-7.
34. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
35. McConkey, D. J., and S. Orrenius. 1994. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:370-375.
36. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
37. Milner, J. 1995. Flexibility: the key to p53 function? Trends Biochem. Sci. 20:49-51.
38. Morii, K., R. Tanaka, Y. Takahashi, and R. Kuwano. 1992. Cloning of cDNAs encoding human S-100α and β subunits and their differential expression in human tumor cell lines. J. Neurosci. Res. 32:27-33.
39. Polyak, K., T. Waldman, T. C. He, K. Kinzler, and B. Vogelstein. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1945-1952.
40. Ryan, J. J., E. Prochownik, C. A. Gottlieb, I. J. Apel, R. Merino, G. Nunez, and M. Clarke. 1994. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. USA 91:5878-5882.
41. Sabapathy, K., M. Klemm, R. Jaenisch, and E. F. Wagner. 1997. Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 16:6217-6229.
42. Schäfer, B. W., and C. Heizmann. 1996. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 21:134-140.
43. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
44. Selinfreund, R. H., S. W. Barger, W. J. Pledger, and L. Van Eldik. 1991. Neurotrophic protein S100b stimulates glial proliferation. Proc. Natl. Acad. Sci. USA 88:3554-3558.
45. Sendtner, M., and H. Thoenen. 1994. Neurodegenerative disease. Oxidative stress and motoneuron disease. Curr. Biol. 4:1036-1039.
46. Sheng, J. G., R. E. Mrak, and W. S. T. Griffin. 1994. S100b protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:398-404.
47. Stanley, L. C., R. E. Mrak, R. C. Woody, L. J. Perrot, S. Zhang, D. R. Marshak, S. J. Nelson, and W. S. Griffin. 1994. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53:231-238.
48. Vikhanskaya, F., E. Erba, M. D'Incalci, and M. Broggini. 1996. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type p53. Exp. Cell Res. 227:380-385.
49. Yahanda, A. M., J. M. Bruner, L. A. Donehower, and R. S. Morrison. 1995. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. Cell. Biol. 15:4249-4259.
50. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347.